CompanyPrivateRedmond, WA

SystImmune, Inc

SEC EDGAR ClinicalTrials.gov

10-QOct 29Latest SEC filing

Form DJun 4$7.2M sold

October 2026

Oncolytics details GOBLET readout timing; SystImmune starts Phase 3 ADC trial in urothelial cancer

Oct 13Trial updateOncolytics Biotech SystImmune, Inc